Molecular Pharmacology (USA) Ltd. Sample Contracts

THIS AGREEMENT is made the day25th of November 2005. BETWEEN: THIS AGREEMENT is made the 25th day of November 2005. BETWEEN: PHARMANET GROUP LIMITED (ABN 98 006 640 553), of Level 1, 284 Oxford Street, Leederville, Western Australia ("Pharmanet"); AND...
Share Purchase Agreement • January 31st, 2006 • Molecular Pharmacology (USA) LTD • Pharmaceutical preparations • Western Australia

Pharmanet is the legal and beneficial owner of the MPL Shares. Pharmanet has agreed to sell and MPLUSA has agreed to purchase the MPL Shares on the terms and conditions set out in this Agreement.

AutoNDA by SimpleDocs
DISTRIBUTION AND SUPPLY AGREEMENT By and Between Molecular Pharmacology Limited (ACN 110 037 860) And: Molecular Pharmacology (USA) Limited DATED: OCTOBER 13, 2005
Distribution Agreement • October 18th, 2005 • Molecular Pharmacology (USA) LTD • Gold and silver ores • Western Australia

Molecular Pharmacology Limited (ACN 110 037 860), a corporation duly organized and existing under the applicable laws of Australia, having an address at Level 1, 284 Oxford Street, Leederville, Western Australia ("MPL").

TRUST AGREEMENT
Trust Agreement • January 23rd, 2003 • Blue Hawk Ventures Inc • British Columbia

BLUE HAWK VENTURES, INC., a company duly incorporated under the laws of the State of Nevada and having an office at Unit 35, 12880 Railway Avenue, Richmond, B.C., V7E 6G4

OPTION TO PURCHASE AND ROYALTY AGREEMENT
Option to Purchase and Royalty Agreement • January 23rd, 2003 • Blue Hawk Ventures Inc • British Columbia

BYRON G. COX, Trustee for BLUE HAWK VENTURES INC., a company duly incorporated under the laws of the State of Nevada, having an office at Unit 35, 12880 Railway Avenue, Richmond, BC, V7E 6G4

DERMATOLOGY DEVELOPMENT CORPORATION
Royalty Agreement • July 19th, 2013 • Molecular Pharmacology (USA) Ltd. • Pharmaceutical preparations

We wish to confirm an agreement between Dermatology Development Corporation (DDC), a corporation organized under the laws of the State of New York, and Molecular Pharmacology Pty Ltd (MPL). This contract covers the potential royalties concerning the brokering by DDC (Services) of MPL USA's products and technology (Products and Technology) to potential partner and distribution companies in the United States of America (Territory).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!